Hydrodissection as a Treatment for Carpal Tunnel Syndrome
NCT ID: NCT03427983
Last Updated: 2019-08-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2018-03-08
2019-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Volume Effect of Nerve Hydrodissection for Carpal Tunnel Syndrome
NCT03381521
Efficacy of Combining Ultrasound-Guided Needle Release of Transverse Carpal Ligament and Median Nerve Dextrose Water Hydrodissection for Carpal Tunnel Syndrome
NCT07324005
Short-Term Effectiveness of Ultrasound-Guided Corticosteroid Hydrodissection
NCT04848324
The Effect of Hydrodissection for Carpal Tunnel Syndrome
NCT02991001
Comparison of Ultrasound-guided Corticosteroid Injection Versus Corticosteroid Injection and Hydrodissection for Carpal Tunnel Syndrome
NCT04346030
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
US-guided regular injection
US in-plane injection with corticosteroid and 1cc of lidocaine. Total of 2cc.
Regular Injection
Corticosteroid and lidocaine injection without additional saline is used as routine treatment.
US-guided hydrodissection
US in-plane injection with corticosteroid and 1cc of lidocaine, and 3cc of saline. Total of 5cc.
Hydrodissection
Additional 3cc's of saline is used to establish an increase in hydrodissection during routine treatment.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hydrodissection
Additional 3cc's of saline is used to establish an increase in hydrodissection during routine treatment.
Regular Injection
Corticosteroid and lidocaine injection without additional saline is used as routine treatment.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* adult men and women between age 21 and 80 AND
* no more than moderate severity as indicated by EMG AND
* symptoms of numbness or tingling for at least 4 weeks in the median nerve distribution area AND
* classic or probable carpal tunnel syndrome on Katz-Stirrat hand diagram AND
* ability to complete English-language questionnaires and clinical evaluations AND
* is reachable by phone for the follow up contact
Exclusion Criteria
* previous history of steroid injection into carpal tunnel OR
* currently taking a steroid medication either regularly or on an as needed basis OR
* any of the following clinical diagnoses or conditions: Cervical radiculopathy; rheumatoid or other inflammatory arthritis, including gout; osteoarthritis in the wrist; renal failure; sarcoidosis; peripheral nerve disease; diabetes, thyroid disease or other metabolic disorder; pregnancy; amyloidosis; or major trauma (fractures or complete ligamentous tears) to the ipsilateral arm OR
* prisoners, institutionalized individuals, or others who may be considered vulnerable populations, such as individuals with dementia
21 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Peter C. Amadio, M.D.
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peter C Amadio, MD
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17-009840
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.